04:08 AM EDT, 09/20/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said late Thursday it priced a public offering of 2 million American depositary shares, each representing one ordinary share, at $150 per ADS.

The offering, expected to close Sept. 23, is subject to customary conditions.

Ascendis also granted underwriters a 30-day option to purchase up to 300,000 additional depositary shares.

The company intends to use estimated net proceeds of about $281.3 million for the commercial preparation and development of drug candidates and for general corporate purposes.

Price: 153.50, Change: +0.07, Percent Change: +0.05